Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs SkyRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and SkyRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 247 · Grade C

SkyRx

Visit SkyRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make SkyRx a bad call — it's best for readers willing to examine an annual commitment and restrictive refund terms before choosing an advertised semaglutide program. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
69
Transparency
90
72
Access Breadth
93
46
Clinical Oversight
92
76
Track Record
88
65
CoreAge RxBrief Score 94 · 66SkyRx

Price, coverage & the tracker

CoreAge RxSkyRx
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Annual prepayment required

Compounded semaglutide injections or oral drops advertised from $199/month with 12 months paid upfront.

Actual total depends on the selected product and plan; this is not a month-to-month quote.

Full price details

Complete selected-plan quote unknown; compounded semaglutide injections or oral drops advertised from $199/month with a 12-month subscription paid upfront in full; actual total depends on selected product and plan

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Labeled coming soon

Tirzepatide injections and oral drops are not established as active offerings.

No available treatment price is confirmed.

Full price details

Tirzepatide injections and oral drops are labeled coming soon; no active treatment quote established

CoverageUS only; restrictions by state, confirmed at intakeGLP-1 page says service is not available in all 50 states; exact eligible states must be confirmed for the selected prescription
Brand-name accessNot confirmedThe named GLP-1 programs are compounded; current brand-name fulfillment was not established.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

SkyRx: The $199 monthly figure requires twelve months paid upfront. Confirm the actual total and renewal timing; cancellation does not guarantee a prepaid-term refund.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.